Glenmark Pharmaceuticals launches ‘Digihaler’

26 May 2016 Evaluate

Glenmark Pharmaceuticals has launched Digihaler, a Digital Dose Inhaler (DDI). This next-gen inhaler provides accurate digital dose counter along with low dose warning indicator to enable asthma and chronic obstructive pulmonary disease (COPD) patients to track adherence to their therapy. The development comes on the back of patients’ compliance being a challenge globally when it comes to chronic disease treatment.

Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. It manufactures and markets generic formulation products and active pharmaceutical ingredients, both in the domestic and international markets.

Glenmark Pharma Share Price

1985.60 -15.00 (-0.75%)
19-Jan-2026 11:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1663.85
Dr. Reddys Lab 1171.55
Cipla 1379.70
Zydus Lifesciences 864.90
Lupin 2176.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×